TAPENTADOL HYDROCHLORIDE
| Brand name | NUCYNTA |
|---|---|
| Active ingredient | TAPENTADOL HYDROCHLORIDE |
| Strength | EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | October 2012 |
| Marketing status | DISCN |
| Code | Expires |
|---|---|
| PED | January 2027 |
| NPP | July 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.